Ms Marina Skiba - Researcher Profile

Biography

Marina has worked in the area of clinical research since early 1991. Her primary role has been to ensure the regulatory and ethical standard of the studies that are conducted within the Clinical Pharmacology Unit and the CCRE in Therapeutics. Marina's teaching includes the Master of Public Health subjects MPH2036 'Controlled Clinical Trials' and MPH2083 ‘Ethics, Good Research Practice and Practical Research Methods' and lectures in the area of Regulatory Affairs and Research Governance. She is the Chair of the SPHPM Research Governance Committee.

Qualifications

B ED (SEC) SCI

Institution: University of Melbourne

Year awarded: 1991

Publications

Journal Articles

Hopper, I., Skiba, M.A., Krum, H., 2012, Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm, European Journal of Heart Failure [P], vol e-pub, Oxford University Press, United Kingdom, pp. 1-10.

Hopper, I., Kemp, W., Porapakkham, P., Sata, Y., Condon, E., Skiba, M., Forber, L., Porapakkham, P., Williams, T., Menahem, S., Roberts, S., Krum, H., 2012, Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography, European Journal of Heart Failure [P], vol 14, issue 6, Oxford University Press, United Kingdom, pp. 621-627.

Hopper, I., Billah, M., Skiba, M., Krum, H., 2011, Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: Meta-analysis of randomised controlled clinical trials, European Journal Of Cardiovascular Prevention & Rehabilitation [P], vol 18, issue 6, Sage Publications Ltd, UK, pp. 813-823.

Crammond, B., Parker, A., Brooks, M., Skiba, M., McNeil, J., 2011, Self-audit as part of a research governance framework for health research, Medical Journal Of Australia [P], vol 194, issue 6, Australasian Medical Publishing Company Pty. Ltd, Australia, pp. 310-312.

Ashton, E., Windebank, E., Skiba, M., Reid, C., Schneider, H., Rosenfeldt, F., Tonkin, A., Krum, H., 2010, Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study, International Journal of Cardiology [P], vol 146, issue 3, Elsevier Ireland Ltd, Ireland, pp. 404-407.

Leet, A., Richardson, M., Senior, J., Funston, R., Skiba, M.A., Bailey, M.J., Krum, H., 2009, A bioavailability study of cyclosporine: comparison of Neoral versus Cysporin in stable heart transplant recipients, Journal of Heart and Lung Transplantation [P], vol 28, issue 9, Elsevier Inc., United States, United Kingdom, France, pp. 894-898.

Brack, J., Sindone, A., Funston, R., Schneider, H., Skiba, M.A., Ueng, K., Krum, H., 2008, Is addition of angiotensin receptor blockade superior to increasing ACE inhibitor dose in patients with heart failure?, International Journal of Cardiology [P], vol 3.469, issue 3, Elsevier Ireland Ltd, Ireland, pp. 309-312.

Szramka, M., Harriss, L.R., Ninnio, D., Windebank, E., Brack, J., Skiba, M.A., Krum, H., 2007, The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease, International Journal of Cardiology, vol 117, issue 2, Elsevier Ireland Ltd, Ireland, pp. 287-291.

Poustie, S.J., Taylor, D.M., Forbes, A.B., Skiba, M.A., Nelson, M.R., McNeil, J.J., 2006, Implementing a research governance framework for clinical and public health research, Medical Journal of Australia, vol 185, issue 11-12, Australasian Medical Publishing Co. Pty Ltd, Australia, pp. 623-626.

Krum, H., Skiba, M.A., Gilbert, R.E., 2003, Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy, Diabetic Medicine, vol 20, issue 9, Blackwell Publishing Ltd, UK, pp. 708-712.

Snell, G.I., Kotsimbos, T.C., Levvey, B., Skiba, M.A., Rutherford, D., Kong, D.C.M., Williams, T.J., Krum, H., 2000, Pharmacokinetic assessment of oral ganciclovir in lung transplant recipients with cystic fibrosis, Journal of Antimicrobial Chemotherapy, vol 45, British Society for Antimicrobial Chemotherapy, UK, pp. 511-516.